Over 20 years’ experience in supplying blinded or converted inhalation devices
The global market has a growing need for inhaled respiratory products and many comparative clinical studies against marketed products need to be conducted. When there is a marked difference between the devices, often a double dummy design is employed.
Within our pioneering innovator service, we offer blinding or conversion to placebo for many inhaler device types. When combined with our on-site analytical and QP services, our service is truly integrated and unique.
Devices and services include:
• MDI (metered dose inhaler)
• DPI (dry powder inhalers)
• DPI – capsule based
• DPI – reservoir based
• Various other formats
• Both blinding and conversion to placebo
• Innovator processes to disassemble / reassemble devices
• Production of specialised blisters in low RH for use as placebo
• Analytical services and testing to prove compliance
• Comparator procurement
Our knowledgeable specialists are available to provide guidance for your blinding or conversion, as we know that careful assessment is required for each device type.
11 December 2019 Seoul, South Korea
Clinical Trial Supply East AsiaEvent info
06 February 2020 Copenhagen, DE
Workshop: Planning for an effective global clinical supply chain by choosing the best distribution, comparator and IOR strategiesEvent info
25 February 2020 West Coast, USA
Workshop: Ensuring Supply Chain Flexibility and Viability for BiologicsEvent info
27 February 2020 Beijing, China
10th Asia Pharma R&D Leaders 2020Event info